Viewing Study NCT03425994


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2025-12-26 @ 5:14 AM
Study NCT ID: NCT03425994
Status: UNKNOWN
Last Update Posted: 2019-08-28
First Post: 2018-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection
Sponsor: National Taiwan University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module